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Abstract Sublethal ischemia leads to increased tolerance 
against subsequent prolonged cerebral ischemia in vivo. In the 
present study we modeled preconditioning mechanisms in a 
neuronal-enriched culture. Damage was significantly reduced (up 
to 72%) with 1.5 h of oxygen-glucose deprivation 48-72 h before 
3 h oxygen-glucose deprivation. Tolerance was also elicited by 
Na+-K+-ATPase inhibition. No damage was observed when 
astroglial or endothelial cells were exposed to hypoxia for 3 and 
6 h, respectively. We conclude that hypoxic preconditioning is a 
robust neuronal phenomenon in vitro with a similar temporal 
pattern and selective cellular vulnerability as the ischemic 
tolerance phenomenon shown in vivo. 
© 1997 Federation of European Biochemical Societies. 
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1. Introduction 
Brief ischemia protects against subsequent prolonged cere-
bral ischemia in vivo, a phenomenon which, first described for 
the myocardium, has attracted considerable attention in brain 
research over the last years since its discovery in 1991 [1] (for 
review, see [2]). As possible underlying molecular mechanisms 
a great variety of mediators have been postulated: induction 
of heat-shock proteins [3], changing activity of respiratory 
enzymes [4], expression of anti-apoptotic factors [5], interleu-
kin-1 [6], N M D A receptors [7] or adenosine receptors and 
ATP-dependent potassium channels [8]. 
In addition, tolerance to ischemia has been elicited by 
spreading depression [9] and inhibition of oxidative phospho-
rylation [10]. 
Exact analysis of tolerance mechanisms, however, has been 
hampered by the complexity of these systems in vivo. Eludi-
cation of this phenomenon in vitro might be useful to increase 
our understanding of drugs designed to prevent or ameliorate 
cerebral ischemia. 
In the present work we developed and established an in 
vitro model of hypoxic and pharmacologic preconditioning 
in a neuronal-cell enriched culture as a basis for future studies 
of induced tolerance to ischemia in the brain. 
2. Materials and methods 
Neuronal cells were used for experiments after 10-12 days in vitro 
(DIV). For oxygen-glucose deprivation (OGD) cells were placed in a 
humidified, temperature controlled (36 ± 0.5°C) chamber at a p0 2 of 
2^1 mmHg (5% C02/95% N2) measured by a polarographic electrode 
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(Licox PO2, GMS, Kiel, Germany). Culture medium was washed out 
three times with PBS containing Ca2+/Mg2+and replaced by a deoxy-
genated solution containing (in mM): Na+ 143.8; K+ 5.5; Ca2+ 1.8; 
Mg2+ 0.8; C r 125.3; HCO^ 26.2; H 2 S0
2 - 1.0; SO|" 0.8; glycine 
0.01 at pH 7.4. The same solution with 25 mM D-glucose under 
normoxia served as control. OGD was then started by placing the 
cells in the hypoxia chamber and terminated by returning the stored 
culture medium and reexposure to normoxia. Cell injury was assessed 
using phase contrast microscopy and by measuring lactate dehydro-
genase release (LDH) in the supernatant after 4 h, 24 h and 48 h. 
LDH has been shown to correspond to the number of damaged neu-
rons [11]. The amount of LDH present in the medium supernatant of 
sham washed cultures was subtracted as background from values of 
treated cultures and OGD values were normalized to 100%. 
Statistical difference between groups was calculated using an un-
paired Student's /-test. 
Cortical neurons were prepared from whole cerebral cortices of 
fetal Wistar rats (E16-17) as described previously [12]. After removing 
of the meninges the tissue was minced and digested with trypsin 
(0.005%; 0.002%, EDTA; 15 min; 37°C) followed by mechanical dis-
sociation. Cells were seeded in 4-well plates (250 000/cm2) and grown 
in neurobasal medium with B-27 serum-free supplement (Gibco, Ger-
many), 100 U/ml penicillin and 100 ug/ml streptomycin and 2 mM L-
glutamine. 80-90% of cells stained positive for neuronal specific eno-
lase (NSE), 10-15% of cells for glial fibrillary acidic protein (GFAP) 
and less than 5% for OX 42, suggesting the presence of microglial 
cells. Antibodies were purchased from DAKO, Hamburg, Germany, 
media and supplements from Biochrom KG, Berlin, Germany, unless 
otherwise noted. 
Primary cultures of cerebral endothelial cells were prepared from 3-
week-old Wistar rats as described previously [13] and used for experi-
ments at DIV 6-8. 
Highly purified astroglial cell-cultures were prepared as described 
previously [14] and used for experiments at DIV 8-10. 
For DNA laddering as an indicator of apoptosis, approximately 106 
cells were harvested after an OGD interval of 180 min and following 
reoxygenation periods of 24 and 48 h, respectively. DNA was ex-
tracted using a modified commercial Easy-DNA Kit (Invitrogen, 
Netherlands). After resuspension in 80 ul TE-buffer (10 mM Tris, 
1 mM EDTA, pH 7.8) DNA concentration was measured by the 
absorbance at 260 nm. For each lane 0.25 ug of DNA were 
[y-32P]ATP-labeled by T4 polynucleotide kinase (NEB) reaction at 
37°C for 30 min. DNA was loaded on a 1% agarose gel and separated 
at 70 V for 180 min. After separation, gel was vacuum-dried and 
exposed afterwards to an X-ray film (Hyperfilm ECL, Amersham) 
film at —70°C for 24 h. For quantification of fragmented DNA, bands 
on the dried gel were analyzed by a Phosphoimager (Molecular Dy-
namics, CA). 
3. Results 
Ninety min oxygen-glucose deprivation (OGD) did not 
cause the LDH-release or morphological alterations of neu-
rons. In contrast, 180 min hypoxia increased L D H release by 
70 ± 8% at 48 h after hypoxia. Under phase contrast micros-
copy 70-90% of neurons appeared degenerated. Since many 
cells exhibited vacuolization and nuclear condensation we 
tested whether this might be due to apoptotic mechanisms. 
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Fig. 1. DNA fragmentation from primary cortical neurons after 
OGD. Cortical neurons were stimulated by OGD. After 24 and 48 
h total DNA was extracted and 0.25 |ig of DNA were separated on 
a 1% agarose gel, and stained with 50 jo.1/1 ethidium bromide. Lanes: 
1, 1-kbp ladder; 2 and 4, control after 24 and 48 h, respectively; 
3 and 5, DNA fragmentation 24 and 48 h after 180 min OGD. 
As shown in Fig. 1 and Table 1, DNA fragmentation was 
already observed in the control and further augmented after 
180 min of OGD followed by 24 h and 48 h reoxygenation, 
respectively. At 24 h after OGD a 3.4-fold increase in typical 
DNA ladder pattern with oligonucleosome-sized fragments of 
180 base pairs was observed. An adjustment of DNA frag-
Table 1 
Semiquantitative analysis of fragmented DNA 
Fragmented-to-non-fragmented DNA ratio 
Control 
OGD 











0.25 ug of DNA were [y-32P]ATP-labeled by T4 polynucleotide kinase, 
loaded on a 1% agarose gel. Separated bands were analyzed by a 
Phosphoimager. Data presented as a ratio between fragmented and 
unfragmented DNA in control and hypoxic stimulated cells. After-
wards DNA fragmentation of stimulated cells is presented as a per-
centage of values found in control. 
mentation of stimulated and control cells was detectable at 
48 h after hypoxia. 
Substantial neuroprotection was observed by phase-con-
trast microscopy when cells were preconditioned by 90 min 
hypoxia 72 h prior to a 180 min hypoxia (Fig. 2 shows rep-
resentative images). In some cases almost complete protection 
by a preconditioning stimulus was observed when only mor-
phologic criteria were employed. The extent of neuronal in-
jury after 180 min. OGD varied between different primary 
cultures but was comparable between sister cultures from a 
single plating. For all subsequent experiments the interval 
between preconditioning OGD (90 min) and prolonged 
OGD (180 min) was varied between 24 h, 48 h and 72 h. 
Fig. 2. Hypoxic preconditioning of cultured neuronal cells. Phase contrast photomicrographs: (A) neuronal cells at DIV 10 (control); (B) 24 h 
after 1.5 h OGD; (C) 24 h after 3 h OGD; (D) 1.5 h OGD 72 h before 3 h OGD; each of the images was recorded 24 h after OGD. 
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Fig. 3. Hypoxic preconditioning of cultured neuronal cells (LDH release): control = sham wash; pre. = 1.5 h OGD alone; hyp. = 3 h OGD 
alone; pre+hyp= 1.5 h OGD 24 h (first row); 48 h (second row) and 72 h (last row) before 3 h OGD. LDH levels after OGD varied between 
103 and 268 U/ml and were normalized to 100%. Data are expressed as means ± standard error. 
Shorter intervals than 24 h did not induce tolerance (data not 
shown). 
Hypoxic LDH-release was attenuated by 6 ±17%, 34 ±7% 
and 39±9% (24 h interval); 41 ±9%, 40± 16% and 72± 19% 
(48 h interval) and 38 ± 9%, 62 ± 14% and 55 ± 11% (72 h) 4 h, 
24 h or 48 h after prolonged OGD, respectively (Fig. 3). Note 
that for some time points (e.g. 72 h interval) there is a ten-
dency towards neuroprotection by preconditioning alone as 
compared to control. Values are means from 8-16 values 
from at least three independent experiments ± standard error. 
To further address the question whether induction of toler-
ance might be due to disturbance of ionic homeostasis, cells 
were pretreated for 2 h with 10 uM ouabain, a potent Na+-
K+-ATPase inhibitor [15]. Hypoxic LDH-release was attenu-
ated by 48 ± 13%, 25 ±7% and 34 ± 14% (24 h interval) and 
0 ± 11%, 45 ± 19% and 13 ± 15% (48 h interval) 4 h, 24 h or 48 
h after prolonged hypoxia, respectively (Fig. 4). Statistical 
difference, however, was reached only for the 24 h interval. 
The ouabain concentrations used showed no toxicity (data not 
shown). 
LDH release from cerebral endothelial cells decreased from 
49.6 ± 1.7 to 24.6 ± 1.4 U/ml 24 h after 3 h OGD. Astrocytes 
released 58.2 ± 1 U/ml LDH in the control group and 57 ±5 
U/ml LDH 24 h after 6 h of OGD (data are means ± standard 
error). 
4. Discussion 
The fact that short hypoxic periods in the central nervous 
system induce tolerance to otherwise lethal hypoxia remains 
mechanistically and therapeutically interesting, but enigmatic. 
To our knowledge, in contrast to the growing in vivo results 
there are few in vitro data regarding hypoxic tolerance. Saka-
ki et al. [16] reported induction of tolerance by 4 h of mild 
hypoxia (calculated p02 of 40 mmHg) in undifFerentiated neu-
ronal cells at 24 h in vitro and a unknown proportion of non-
neuronal cells present. 
Lobner at al. [17] reported pharmacologic preconditioning 
with protein synthesis inhibitors in a mixed cortical culture at 
14-16 days in vitro which was possibly due to reduced gluta-
mate release. 
Compatible with results shown in hypoxic brain slices [10] 
and in vivo models of global [1] and focal ischemia [18] and F. 
Wiegand and U. Dirnagl (personal communication) we found 
that brief, non-lethal oxygen-glucose deprivation can protect 
neurons from hypoxic damage. 
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Fig. 4. Ouabain preconditioning of cultured neuronal cells (LDH release): control = sham wash; ou = 2 h ouabain 10 uM alone; hyp. 
OGD alone; ou+hyp = 2 h ouabain 24 h (first row) or 48 h (second row) before 3 h OGD. Data are expressed as means ± standard error. 
= 3 h 
In addition we suggest that preconditioning is rather a neu-
ronal phenomenon since astrocytes represent only a minor 
population and are not damaged by hypoxia in our system. 
However, we cannot rule out that astrocytes 'sense' hypoxia 
and subsequently produce neuroprotective or neurotrophic 
factors. In accordance to in vivo systems, neurons in vitro 
seem to maintain their 'selective vulnerability' as compared 
to other CNS cell types like astrocytes [19] or endothelial cells 
which have been shown to tolerate more prolonged hypoxic 
phases [20]. 
We observed that prolonged hypoxia seems to activate 
DNA fragmentation in our system. However, apoptosis is 
an inherent phenomenon in neuronal cell cultures [21]. We 
believe that our system, which can be maintained viable max-
imally 20 days (death occurs possibly due to a lack of trophic 
factors normally provided by astroglial cells), might be useful 
to study preconditioning but may not be less suited to distin-
guish necrosis from apoptosis after hypoxia. 
In addition we demonstrated that preconditioning can also 
be elicited pharmacologically by ouabain, albeit to a lesser 
extent. We can only speculate why ouabain leads to tolerance 
induction. Inhibition of Na+-K+-ATPase by ouabain leads to 
imbalance in ionic homeostasis and might therefore mimic 
ischemic or hypoxic conditions [15]. Ouabain is a well estab-
lished cardiac glycoside [22] with binding sites found also in 
brain [23]. Future studies will be needed to test whether this 
substance might be an interesting candidate for pharmaco-
logic preconditioning. 
In summary we have shown that induction of ischemic tol-
erance can be modeled in vitro. Our neuronal cell enriched 
system showed preconditioning within a time frame and with 
a 'selective' cellular vulnerability compatible to in vivo con-
ditions. Future studies are needed to delineate the 'point of no 
return', where lack of oxygen turns from an signal in to an 
lethal condition. In future our model might prove useful to 
examine selective cellular expression of genes involved in reg-
ulation of apoptosis and or neurotrophic factors. 
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